4.7 Article

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation

期刊

JOURNAL OF CELL BIOLOGY
卷 211, 期 5, 页码 975-985

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201505119

关键词

-

资金

  1. United Kingdom Multiple Sclerosis Society
  2. Wellcome Trust
  3. Sir David and Isobel Walker Trust
  4. Medical Research Council
  5. Investissements d'avenir Instituts Hospitalo-Universitaires A Institut du Cerveau et de la Moelle Epiniere
  6. National Health and Medical Research Council [628928]
  7. Obra Social La Caixa
  8. MRC [MC_PC_12012] Funding Source: UKRI
  9. Medical Research Council [MC_PC_12012] Funding Source: researchfish
  10. Rosetrees Trust [M144] Funding Source: researchfish

向作者/读者索取更多资源

The mechanisms regulating differentiation of oligodendrocyte (OLG) progenitor cells (OPCs) into mature OLGs are key to understanding myelination and remyelination. Signaling via the retinoid X receptor gamma (RXR-gamma) has been shown to be a positive regulator of OPC differentiation. However, the nuclear receptor (NR) binding partner of RXR-gamma has not been established. In this study we show that RXR-gamma binds to several NRs in OPCs and OLGs, one of which is vitamin D receptor (VDR). Using pharmacological and knockdown approaches we show that RXR-VDR signaling induces OPC differentiation and that VDR agonist vitamin D enhances OPC differentiation. We also show expression of VDR in OLG lineage cells in multiple sclerosis. Our data reveal a role for vitamin D in the regenerative component of demyelinating disease and identify a new target for remyelination medicines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据